Scholars Central

Conference abstractPublished 20 Jul 2015

Novel therapeutic approach to inhibit innate immune cell trafficking in inflammation using chemokines and their binding molecules

Authors: Jim Middleton, Emily McNaughton, Richard Sessions, Michele Farris, Robert Broadbridge, Andreas Kungl

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chemokines are involved in driving leukocyte migration into inflamed tissue. They achieve this by being presented to blood leukocytes by heparan sulphate proteoglycans (HSPGs) on the luminal surface of vascular endothelial cells. We have found that in the synovial endothelial cells of rheumatoid arthritis patients there is induction of a CXCL8 binding site on the HSPG syndecan-3. This suggests involvement of syndecan-3 in leukocyte trafficking into the synovium. Indeed we have shown that leukocyte accumulation and cartilage damage is reduced in syndecan-3 null mice with antigen-induced arthritis. Addition of soluble syndecan-3 in vitro binds chemokines CCL2 and CCL7, and redcues chemotactic responses of moncytes to these chemokines. Injection of soluble syndecan-3 reduces leukocyte accumulation and arthritis severity in antigen-induced arthritis. HSPGs interact with basic residues in chemokines. Therefore addition of competing peptides containing these residues should be inhibitory. Indeed we have found some chemokine peptides do inhibit chemokine-HSPG interaction. These peptides bind HS and inhibit chemokine-driven migration of neutrophils across brain microvascular endothelial cells in vitro. Furthermore these chemokine peptides reduce the swelling of joints of mice with antigen-induced arthritis. In conclusion targeting chemokine-HSPG interactions by adding competing soluble HSPGs (syndecans) and chemokine peptides have therapeutic effects and represents a novel therapeutic approach to inhibit innate immune cell trafficking.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Jim Middleton”
  • BylineArticles whose byline prints “Emily McNaughton”
  • BylineArticles whose byline prints “Richard Sessions”
  • BylineArticles whose byline prints “Michele Farris”
  • BylineArticles whose byline prints “Robert Broadbridge”
  • BylineArticles whose byline prints “Andreas Kungl”